Skip to main content

Published locations for OS benefit with pembrolizumab endures long-term in advanced NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. OS benefit with pembrolizumab endures long-term in advanced NSCLC

User login

  • Reset your password
  • /content/os-benefit-pembrolizumab-endures-long-term-advanced-nsclc
  • /oncologypractice/article/208692/lung-cancer/os-benefit-pembrolizumab-endures-long-term-advanced
  • /jcomjournal/article/208692/lung-cancer/os-benefit-pembrolizumab-endures-long-term-advanced-nsclc
  • /hematology-oncology/article/208692/lung-cancer/os-benefit-pembrolizumab-endures-long-term-advanced